Literature DB >> 11531985

Effect of step-down therapy of ceftriaxone plus loracarbef versus parenteral therapy of ceftriaxone on the intestinal microflora in patients with community-acquired pneumonia.

F Vogel1, H R Ochs, K Wettich, S Kalich, I Nilsson-Ehle, I Odenholt, C E Nord.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11531985     DOI： 10.1046/j.1198-743x.2001.00264.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN： 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

Review 1.  Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Authors:  Harriet M Lamb; Douglas Ormrod; Lesley J Scott; David P Figgitt
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Impact of antimicrobial therapy on the gut microbiome.

Authors:  Amira A Bhalodi; Tjitske S R van Engelen; Harjeet S Virk; W Joost Wiersinga
Journal:  J Antimicrob Chemother       Date:  2019-01-01       Impact factor: 5.790

3.  Third generation cephalosporins and piperacillin/tazobactam have distinct impacts on the microbiota of critically ill patients.

Authors:  Hasinika K A H Gamage; Carola Venturini; Sasha G Tetu; Masrura Kabir; Vineet Nayyar; Andrew N Ginn; Belinda Roychoudhry; Lee Thomas; Mitchell Brown; Andrew Holmes; Sally R Partridge; Ian Seppelt; Ian T Paulsen; Jonathan R Iredell
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

Review 4.  Human gut microbiota: repertoire and variations.

Authors:  Jean-Christophe Lagier; Matthieu Million; Perrine Hugon; Fabrice Armougom; Didier Raoult
Journal:  Front Cell Infect Microbiol       Date:  2012-11-02       Impact factor: 5.293
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.